Overall rank by patents
#34,802
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Cellavision AB
USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL).
7
Total patents granted
9
CPC technology areas
15.4
Avg claims per patent
-83%
5-year filing velocity
The verdict
Cellavision holds 7 US patents across 9 technology areas, rank #34,802 of 50,000 tracked assignees.
- #34,802
- of 50,000 US assignees by volume
- Top 55%
- by Innovation Score (33.7/100)
- 15.4
- avg claims per patent
- -83%
- filing velocity, last 5 yrs
Portfolio overview
Cellavision AB has been granted 7 US utility patents between 2015 and 2024, placing Cellavision AB at rank #34,802 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL). As a Foreign Corporation, Cellavision AB is one of the more focused assignees in the PatentsView dataset. By volume, Cellavision sits between Catheter Connections, Inc. (7 patents, rank #34,798) and Cellotape, Inc. (7 patents, rank #34,806) - the closest US assignees by grant volume. The composite Innovation Score of 33.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 6 in the 2015–2019 window, a -83% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cellavision AB's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cellavision AB against peers pursuing similar technology classes.
Who files at Cellavision's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Catheter Connecti…
Catheter Connections, Inc.
7 patents
- Cazena
Cazena, Inc.
7 patents
- Cegnum
Cegnum LLC
7 patents
- Cell and Molecula…
Cell and Molecular Tissue Engineering, LLC
7 patents
- Cellaed Life Save…
Cellaed Life Saver PTY LTD
7 patents
- Cellink AB
Cellink AB
7 patents
- Cellink Bioprinti…
Cellink Bioprinting AB
7 patents
- Cellotape
Cellotape, Inc.
7 patents
- Cellavision AB ◀
CellaVision AB
7 patents
What this shows Cellavision holds 7 patents at rank #34,802, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cellavision
By rank, the assignees closest to #34,802 in granted patent volume.
- Catheter Connections, Inc. #34,798 · 7 patents
- Cazena, Inc. #34,799 · 7 patents
- Cegnum Llc #34,800 · 7 patents
- Cell And Molecular Tissue Engineering, Llc #34,801 · 7 patents
- Cellaed Life Saver PTY Ltd #34,803 · 7 patents
- Cellink AB #34,804 · 7 patents
- Cellink Bioprinting AB #34,805 · 7 patents
- Cellotape, Inc. #34,806 · 7 patents
Leaders in G06T (Image DATA Processing OR Generation)
Other assignees with the most granted patents in Cellavision's primary technology class.
- Samsung Electronics Co., Ltd. 4,120 in class
- Canon Kabushiki Kaisha 3,282 in class
- Apple Inc. 2,522 in class
- SONY Group Corporation 2,484 in class
- Intel Corporation 2,439 in class
- Microsoft Technology Licensing, Llc 2,389 in class
- International Business Machines Corporation 2,281 in class
- Google Llc 2,182 in class
Cellavision's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 55% higher than 45% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2017 | 3 | 42.9% |
| 2018 | 1 | 14.3% |
| 2019 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
Which technologies does Cellavision AB patent most?
Top 9 of 9 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Cellavision AB hold?
Cellavision AB holds 7 US granted patents filed between 2015 and 2024, spanning 9 technology areas.
What is Cellavision AB's Innovation Score?
Cellavision AB has an Innovation Score of 33.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cellavision AB focus on?
Cellavision AB's top technology area is G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL) with 4 patents. The company has filed patents in 9 CPC subclasses total.
Is Cellavision AB's patent filing rate increasing or decreasing?
Cellavision AB's recent filing velocity is -83% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Cellavision AB's patents?
Cellavision AB's patents average 15.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Cellavision AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Cellavision's 7 grants land it in the top 55% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Cellavision ranks #34,802 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G06T - see who else leads that technology area. G06T leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.